NCT06493981View on ClinicalTrials.gov

Outcomes in Bone Marrow Aplasia.

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2030

Conditions

Aplastic Anemia Idiopathic

Interventions

DRUG

Eltrombopag

Treatment with eltrombopag in a dose of (50-150mg/d)

All Listed Sponsors

lead

Assiut University

OTHER